Outcomes in Neovascular Age-Related Macular Degeneration After Copayment Assistance Defunding
This cohort study evaluates the implications of copayment assistance discontinuation for treatment strategies and clinical outcomes in patients needing high-cost anti–vascular endothelial growth factor drugs for neovascular age-related macular degeneration.
Authors
- William Carrera (ORCID: https://orcid.org/0000-0001-9053-4089)
- Jesse J. Jung (ORCID: https://orcid.org/0000-0002-1688-3894)
- Kai Xiong Cheong (ORCID: https://orcid.org/0000-0001-9302-1107)
- Soraya Rofagha (ORCID: https://orcid.org/0000-0001-5911-8810)
- Quan V. Hoang
- Anne Zeng
Institutions
- National University of Singapore (SG)
- University of California, San Francisco (US)
- Singapore National Eye Center (SG)
- California Retina Consultants (US)
- Singapore Eye Research Institute (SG)
- Duke-NUS Medical School (SG)
- Columbia College (CA)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1001/jamaophthalmol.2026.2093
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00